Mostrando 1 - 7 Resultados de 7 Para Buscar 'SUPPLY AND DEMAND', tiempo de consulta: 0.38s Limitar resultados
  1. 1
    “…OBJECTIVE: To compare the market dynamics of biosimilar infliximab among four Organization for Economic Cooperation and Development (OECD) countries (UK, France, Japan, and Korea) where supply-side and demand-side policies varied greatly, given high and growing expenditure on biological medicines to treat immunological diseases across countries. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?
  2. 2
    por Simoens, Steven
    Publicado 2009
    “…The policy analysis focuses on supply-side measures (i.e. market access, pricing, reference-pricing and reimbursement of generic medicines) and demand-side measures (i.e. incentives for physicians to prescribe, for pharmacists to dispense and for patients to use generic medicines). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Portuguese generic medicines market: a policy analysis
  3. 3
    “…The moment a supply problem is considered as a shortage, can be defined at four levels: (i) demand side, (ii) supply side, (iii) delivery of a drug, and (iv) availability of a drug. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Toward a European definition for a drug shortage: a qualitative study
  4. 4
    “…Generic medicines can generate larger savings to health care budgets when their use is supported by incentives on both the supply-side and the demand-side. Pharmacists’'remuneration is one factor influencing the dispensing of generic medicines. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing?
  5. 5
    “…BACKGROUND: In the face of rising demand for medical services due to ageing populations, physician migration flows are increasingly affecting the supply of physicians in Organisation for Economic Co-operation and development (OECD) countries. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Impact, regulation and health policy implications of physician migration in OECD countries
  6. 6
    “…Topics were organized in five themes: availability, pricing, reimbursement, demand-side policies, and recommendations to enhance uptake. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Policies for biosimilar uptake in Europe: An overview
  7. 7
    “…These measures should account for the particularities of off-patent biologic and biosimilar markets and should jointly address supply- and demand-side challenges.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An exploration of biosimilar TNF-alpha inhibitors uptake determinants in hospital environments in Italy, Portugal, and Spain
Herramientas de búsqueda: RSS